Congratulations to CBI faculty member Stephen Fried for receiving a grant from the Research Corporation for Science Advancement to study the virus that causes COVID-19. Stephen and his co-investigators will look for ways to block an important mechanism that is related to viral replication and could lead to a new family of antiviral drugs effective against SARS-CoV-2, SARS, MERS, Zika, and other deadly viruses.
Chemistry-Biology Interface Program > About > News Archive > Stephen Fried Receives Research Corporation for Science Advancement